Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v13-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2019-07-03 | 2019-04-18 |
| Drug Identification Number | 02298813 | 02298813 |
| Brand name | EMEND TRI-PACK | EMEND TRI-PACK |
| Common or Proper name | aprepitant capsules | aprepitant capsules |
| Company Name | MERCK CANADA INC | MERCK CANADA INC |
| Ingredients | APREPITANT APREPITANT | APREPITANT APREPITANT |
| Strength(s) | 125MG 80MG | 125MG 80MG |
| Dosage form(s) | KIT CAPSULE | KIT CAPSULE |
| Route of administration | ORAL | ORAL |
| Packaging size | 3cap | 3cap |
| ATC code | A04AD | A04AD |
| ATC description | ANTIEMETICS AND ANTINAUSEANTS | ANTIEMETICS AND ANTINAUSEANTS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2019-08-05 | 2019-07-08 |
| Actual start date | ||
| Estimated end date | 2019-08-19 | 2019-08-26 |
| Actual end date | ||
| Shortage status | Anticipated shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Other individual formats (80MG 2CAP & 125MG 6CAP) are not affected | |
| Health Canada comments |